Did Cigna deserve its $172M fine?

The latest stories trending on MedCity News.

Editor's Pick

Top Story Did Cigna Deserve its $172M Penalty? Cigna recently agreed to pay $172 million to resolve allegations that it violated the False Claims Act. One expert said this is just a small part of the problem, while another called for more clarity from the government. Sponsored Content Startups: Apply for Nashville's Project Healthcare 2024 Cohort by Oct 13! Presented by Nashville Entrepreneur Center and MedCity News Nashville Entrepreneur Center is seeking applications from healthcare startups to take part in its Project Healthcare 2024 cohort.  Applications must be submitted by October 13 to be considered for the 2024 cohort! Click here to apply!

Featured News

Can AI Solve the Adderall Shortage? As we navigate the challenges of drug shortages, especially vital medications like Adderall, it's crucial to be proactive. Predictive analytics, coupled with a deep understanding of alternative drugs, can guide our path forward. Instacart Partners with Mount Sinai, Launches Co-Branded MA Plans with Alignment Through a partnership with Mount Sinai Solutions, Instacart is offering post-operative and post-partum patients a grocery stipend. Instacart is also launching co-branded Medicare Advantage plans with Alignment Healthcare that address food insecurity issues for seniors. Beyond Birth: Improving the Maternal Mental Health Crisis In response to the urgent need for support, the federally funded National Maternal Mental Health […] Headway Raises $125M, Reaches Unicorn Status Headway closed a $125 million Series C funding round. The round brings the New York-based startup's valuation to $1 billion, reaching unicorn status. The company connects patients to in-network therapists and helps mental health providers avoid the massive administrative burden associated with taking insurance. Diana Health Snags $34M to Grow Its Network of Women's Health Practices Diana Health, which partners with hospitals to operate a network of maternity practices, closed a $34 million Series B funding round. The startup currently operates three women's health practices in Tennessee. With its new funding, the company plans to open new practices in Tennessee, Florida and one other yet-to-be-announced state. Kyowa Kirin Buys Into Gene Therapy With Orchard Therapeutics Acquisition The Orchard Therapeutics acquisition comes as the biotech's gene therapy for metachromatic leukodystrophy approaches a March 2024 FDA decision. The ex vivo gene therapy is already commercialized in Europe, marketed as Libmeldy.

Resources

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Chris Allen, CFO at Keck Medicine of USC For September's guest interview, we were joined by Chris Allen, who recently became CFO at Keck Medicine of USC. Some of his recent past roles include CFO of Adventist Health and senior director of budget and decision support at UC Irvine Health. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe